California State Teachers Retirement System (CalSTRS)’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$447K Sell
19,367
-2,314
-11% -$52.3K ﹤0.01% 2104
2025
Q4
$436K Buy
21,681
+3,120
+17% +$64.9K ﹤0.01% 2143
2025
Q3
$342K Buy
18,561
+5,539
+43% +$109K ﹤0.01% 2189
2025
Q2
$283K Sell
13,022
-627
-5% -$13K ﹤0.01% 2214
2025
Q1
$252K Hold
13,649
﹤0.01% 2262
2024
Q4
$364K Buy
13,649
+11,585
+561% +$333K ﹤0.01% 2241
2024
Q3
$48.5K Buy
2,064
+1,353
+190% +$30.7K ﹤0.01% 2431
2024
Q2
$13.2K Sell
711
-278
-28% -$4.96K ﹤0.01% 2777
2024
Q1
$17.7K Buy
+989
New +$19.9K ﹤0.01% 2771

Other funds holding AVBP

California State Teachers Retirement System (CalSTRS)'s AVBP Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its ArriVent BioPharma (AVBP) stake by 11% in Q1 2026, selling an estimated $52.3K and leaving 19,367 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #2104.

California State Teachers Retirement System (CalSTRS) first reported a position in AVBP in Q1 2024 and has held it in 9 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 19,367 shares of ArriVent BioPharma worth $447K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 2,314 ArriVent BioPharma shares in Q1 2026, an estimated $52.3K.
  • ArriVent BioPharma made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2104 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 9 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.